The discovery of the inhibitory immune checkpoint molecules programmed cell death protein 1 and its ligand (PD-1 and PD-L1), as well as the cytotoxic T lymphocyte–associated antigen 4 (CTLA-4), has undeniably advanced the landscape of cancer control [1]. The gene discussed is PDCD1; the disease is cancer.